SOLAI Limited (SLAI)

SELLAS Life Sciences Group Inc. surged as promising clinical news boosted investor optimism; stocks have been trading up by 14.72 percent. Key Takeaways For SLS Traders Q1 loss came in at $0.05 per share, beating the $0.06 Street view and improving from a $0.07 loss last year.

Following the last earnings report on Nov 21, 2025, SOLAI Ltd (SLAI)'s stock price moved — from — to —.

Why Silgan Holdings (SLGN) Stock Is Trading Up Today

SELLAS Life Sciences Group Inc. stocks have been trading down by -12.54 percent following negative sentiment over its latest clinical developments. Key Takeaways SLS has run from the mid-$4s to the high-$8s in May 2026, with the latest daily candle showing a sharp pullback and elevated volatility.

/PRNewswire/ -- SOLAI Limited (NYSE: SLAI) (previously traded under "BTCM") ("SOLAI" or the "Company"), a technology-driven personal AI and digital...